Related Tags >> FDA Adderall ADHD Generics

Shire Pharmaceuticals News

Most Popular Shire Pharmaceuticals Story

ALSO NOTED: CRO market hits $14B; Merck ends BioXell pact; and much more...

July 20, 2007 — 6:59am ET

> Merck has ended its collaboration with BioXell on its sepsis drug TREM-1. BioXell says it will seek another company with which to partner on the drug. Report > Shire... Read more...

Shire Pharmaceuticals Press Releases

Latest Headlines

MA governor to biotechs: Work with the unions
April 17, 2009
Jerini divests assets, focuses on icatibant
October 10, 2008
Shire to buy Jerini in $521M deal
July 3, 2008
Mixed data for Renovo's scarring therapy
March 3, 2008
Shire, Amicus forge $440M pact
November 8, 2007
Shire's Fosrenol flunks mid-stage trial for CKD
November 6, 2007
ALSO NOTED: Big CEO turnover at Big Pharma; New company takes on RNAi field; Shire hunts for buyouts; and much more...
November 2, 2007
ALSO NOTED: Bavarian Nordic earns milestone payment; Cyclacel acquires Align Pharmaceuticals; and much more...
October 8, 2007
SPOTLIGHT: M&A is the future for Big Pharma
October 1, 2007
3. Shire and Renovo
September 11, 2007
Shire to Massachusetts: Pass incentive bill now
August 31, 2007
ALSO NOTED: Avandia gets Black Box Warning; Shire licensing deal complete; Pittsburgh companies gain financing; and much more..
August 15, 2007
Noven garners $25M payday on sales milestone
July 31, 2007
ALSO NOTED: CRO market hits $14B; Merck ends BioXell pact; and much more...
July 20, 2007
Progeria trial underscores challenge of rare diseases
January 29, 2007
SPOTLIGHT: Avexa gains rights to HIV drug
January 22, 2007
Press Release: FDA Approves Shire's Lialda
January 17, 2007
FDA approves Shire's new ulcerative colitis drug
January 16, 2007
C&L: John Higgins tapped to run Ligand
January 16, 2007
ALSO NOTED: Shire drug gets second approvable letter; Galapagos acquires ProStrakan sub; FDA asks Allergan for more data; and m
December 21, 2006

Paid Research Reports

More Research Reports >>